We will be attending the AACR Annual Meeting in New Orleans, from April 8 to 13, 2022. We will be glad to take this opportunity to meet you there, approach your research projects and introduce our service offerings. We will also presentsome scientific posters to highlight our latest innovative preclinical and translational research advances.
We will be attending the AACR Annual Meeting in New Orleans, from April 8 to 13, 2022. We will be glad to take this opportunity to meet you there, approach your research projects and introduce our service offerings. We will present the following scientific posters to highlight our latest innovative preclinical and translational research advances.
|
 |
|
622 / 7 “Development and characterization of a novel anti-PD1 resistant sarcoma mouse model”
Presenter: Alban Bessede
Sunday, April 10, 2022 / 1:30 PM – 5:00 PM
Session PO.IM02.14 – Immune response to therapies 2 / Immune monitoring and clinical correlate
Section 39
|
|
|
|
1251 / 23 “Low plasma Arginine level is associated with resistance to immune checkpoint blockers in patients with advanced cancer”
Presenter: Jean-Philippe Guegan
Monday, April 11, 2022 / 9:00 AM – 12:30 PM
Session PO.CL11.06 – Biomarkers predictive of therapeutic benefit 1
Section 30
|
|
 |
|
|
 |
|
2578 / 17 “High regulatory T cells infiltrate within tertiary lymphoid structure restricts response to immune checkpoint blockers in sarcomas”
Presenter: Florent Peyraud
Tuesday, April 12, 2022 / 9:00 AM – 12:30 PM
Session PO.ET06.09 – Cell cycle, replication inhibitors, and immunotherapy agents
Section 21
|
|
|
|
2527 / 20 “Ovarian cancer ascites display altered immune environment featured by enhanced soluble factors and suppressive cellular context”
Presenter: Imane Nafia
Tuesday, April 12, 2022 / 9:00 AM – 12:30 PM
Session PO.TB06.09 – Organ-specific tumor microenvironment 1
Section 14
|
|
 |
|
